CA-4948
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for CA-4948, covering 2024-08-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer [Phase 1]